HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Accumulation of tubular structures in oligodendroglial and neuronal cells as the basic alteration in multiple system atrophy.

Abstract
In 8 brains of patients with various combinations of striatonigral degeneration, olivopontocerebellar atrophy and Shy-Drager syndrome, inclusion bodies were demonstrated in the cytoplasm and nucleus of both neuronal and oligodendroglial cells and in neuronal processes by means of silver staining, immunocytochemistry and electron microscopy. Differing from oligodendroglial cytoplasmic inclusions recognized by anti-ubiquitin, anti-alpha- and anti-beta-tubulin, and anti-tau antibodies, neuronal cytoplasmic inclusions were stained only by anti-ubiquitin antibody but not with those raised against cytoskeletal proteins. Tubular structures forming the inclusion bodies irrespective of their glial or neuronal location, have fuzzy cover and side extensions which make them similar to the linear structures described in motor neuron diseases. Our study proves that the accumulation of abnormal tubular structures in both oligodendrocytes and neurons is the basic pathological alteration in multiple system atrophy and defines multiple system atrophy as a group of diseases with similar cellular pathology or as a nosological entity.
AuthorsM I Papp, P L Lantos
JournalJournal of the neurological sciences (J Neurol Sci) Vol. 107 Issue 2 Pg. 172-82 (Feb 1992) ISSN: 0022-510X [Print] Netherlands
PMID1314292 (Publication Type: Journal Article)
Topics
  • Atrophy
  • Brain (pathology, ultrastructure)
  • Brain Diseases (pathology)
  • Cell Nucleus (ultrastructure)
  • Female
  • Humans
  • Inclusion Bodies (ultrastructure)
  • Male
  • Microscopy, Electron
  • Middle Aged
  • Neurons (pathology, ultrastructure)
  • Oligodendroglia (pathology, ultrastructure)
  • Olivopontocerebellar Atrophies (pathology)
  • Shy-Drager Syndrome (pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: